Article
The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample.
BMC geriatrics - 14 Jul 2008
Christensen Helen, Batterham Philip J, Mackinnon Andrew J, Jorm Anthony F, Mack Holly A, Mather Karen A, Anstey Kaarin J, Sachdev Perminder S, Easteal Simon
Abstract excerpt
BACKGROUND: While the evidence of an association between the apolipoprotein E (APOE) *E4 allele and Alzheimer's disease is very strong, the effect of the *E4 allele on cognitive decline in the general population is more equivocal. A cross-sectional study on the lifespan effects of the *E4 allele 1 failed to find any effect of the *E4 allele on cognitive performance at ages 20-24, 40-44 or 60-64 years. METHODS: In...
Topics
- Adult
- Aged
- Alzheimer Disease
- Apolipoproteins E
- Australia
- Cognition Disorders
- Cross-Sectional Studies
- Female
- Follow-Up Studies
- Genotype
- Geriatric Assessment
